TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Pharmaceutical Product Development, Inc. Directors Hit By Investor Lawsuit Against Takeover

  • If you purchased shares of Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

San Diego, Oct. 14, 2011 (Shareholders Foundation) -- An investor in Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) filed a lawsuit against directors of Pharmaceutical Product Development in effort to block the takeover attempt of Pharmaceutical Product Development by affiliates of The Carlyle Group and Hellman & Friedman for $33.25 per PPDI share. According to the comp...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: